Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer

被引:1
|
作者
Qiu, Yu [1 ,2 ]
Chen, Yan [1 ,2 ]
Shen, Haoyang [1 ,2 ]
Yan, Shuixin [1 ,2 ]
Li, Jiadi [1 ,2 ]
Wu, Weizhu [1 ,3 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315000, Peoples R China
[2] Ningbo Univ, Hlth Sci Ctr, Ningbo 315000, Zhejiang, Peoples R China
[3] Affiliated Lihuili Hosp, 1111 Jiangnan Rd, Ningbo 315000, Zhejiang, Peoples R China
关键词
triple-negative breast cancer; Naples prognostic score; prognostic factor; nomogram predictive model; INFLAMMATION;
D O I
10.2147/JIR.S472917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: This study investigated the correlation between the Naples prognostic score (NPS), clinicopathological traits, and the postoperative prognoses of patients with triple-negative breast cancer (TNBC). Based on NPS, a predictive nomogram was developed to estimate the long-term survival probabilities of patients with TNBC post-surgery. Patients and Methods: We retrospectively examined the clinical records of 223 women with TNBC treated at Ningbo Medical Center, Lihuili Hospital between January 1, 2016 and December 31, 2020. Blood tests and biochemical analyses were conducted before surgery. The prognostic nutritional index (PNI), controlling nutritional status (CONUT), neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and NPS were determined based on blood-related markers. A Kaplan-Meier survival analysis assessed the association between NPS, PNI, CONUT score, overall survival (OS), and breast cancer-specific survival (BCSS). Predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUC) and C index. The patients were randomly divided into the training and the validation group (6:4 ratio). A nomogram prediction model was developed and evaluated using the R Software for Statistical Computing (RMS) package. Results: NPS outperformed other scores in predicting inflammation outcomes. Patients with an elevated NPS had a poorer prognosis (P<0.001). Lymph node ratio (LNR), surgical method, postoperative chemotherapy, and NPS independently predicted OS, whereas M stage, LNR, and NPS independently predicted BCSS outcome. The OS and BCSS predicted by the nomogram model aligned well with the actual OS and BCSS. The decision curve analysis showed significant clinical utility for the nomogram model. Conclusion: In this study, NPS was an important prognostic indicator for patients with TNBC. The nomogram prognostic model based on NPS outperformed other prognostic scores for predicting patient prognosis. The model demonstrated a clear stratification ability for patient prognosis, which emphasized the potential benefits of early intervention for high-risk patients. Plain Language Summary: In this study, we aimed to understand how the Naples prognostic score (NPS) scoring system could predict the prognosis for patients with triple-negative breast cancer (TNBC). TNBC is a type of breast cancer that can be difficult to treat. Medical records of 223 women with TNBC were retrospectively analyzed. These women had their blood tested before surgery to check for certain markers related to nutrition and inflammation. NPS was used along with other scores to determine their accuracy in predicting survival. NPS was better at predicting outcomes than the other scores. The patients with higher NPS scores tended to have poorer outcomes. We also created a visual tool called a nomogram to help doctors predict patient outcomes based on the NPS scores. NPS can be a valuable tool for doctors treating patients with TNBC because it can help them predict how well a patient might do after surgery. This information could be used to tailor treatment plans for these patients. The nomogram provides a user-friendly way for doctors to use NPS in their practice. Overall, this study showed that NPS is a powerful tool for predicting outcomes for patients with TNBC, which could lead to better treatment decisions and improved outcomes for these patients.
引用
收藏
页码:5253 / 5269
页数:17
相关论文
共 50 条
  • [31] Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients
    Nagahashi, Masayuki
    Ling, YiWei
    Toshikawa, Chie
    Hayashida, Tetsu
    Kitagawa, Yuko
    Futamura, Manabu
    Kuwayama, Takashi
    Nakamura, Seigo
    Yamauchi, Hideko
    Yamauchi, Teruo
    Kaneko, Koji
    Kanbayashi, Chizuko
    Sato, Nobuaki
    Tsuchida, Junko
    Moro, Kazuki
    Nakajima, Masato
    Shimada, Yoshifumi
    Ichikawa, Hiroshi
    Lyle, Stephen
    Miyoshi, Yasuo
    Takabe, Kazuaki
    Okuda, Shujiro
    Wakai, Toshifumi
    BREAST CANCER, 2023, 30 (04) : 584 - 595
  • [32] Systemic treatment in triple-negative breast cancer patients - standard and novel approaches
    Debska-Szmich, Sylwia
    Potemski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (06): : 399 - 414
  • [33] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [34] Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients
    Kamiya, Saki
    Satake, Hiroko
    Hayashi, Yoko
    Ishigaki, Satoko
    Ito, Rintaro
    Kawamura, Mariko
    Taoka, Toshiaki
    Iwano, Shingo
    Naganawa, Shinji
    BREAST CANCER, 2022, 29 (01) : 164 - 173
  • [35] Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients
    Masayuki Nagahashi
    YiWei Ling
    Chie Toshikawa
    Tetsu Hayashida
    Yuko Kitagawa
    Manabu Futamura
    Takashi Kuwayama
    Seigo Nakamura
    Hideko Yamauchi
    Teruo Yamauchi
    Koji Kaneko
    Chizuko Kanbayashi
    Nobuaki Sato
    Junko Tsuchida
    Kazuki Moro
    Masato Nakajima
    Yoshifumi Shimada
    Hiroshi Ichikawa
    Stephen Lyle
    Yasuo Miyoshi
    Kazuaki Takabe
    Shujiro Okuda
    Toshifumi Wakai
    Breast Cancer, 2023, 30 : 584 - 595
  • [36] Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
    Agostinetto, Elisa
    Eiger, Daniel
    Punie, Kevin
    de Azambuja, Evandro
    CURRENT ONCOLOGY REPORTS, 2021, 23 (05)
  • [37] Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort
    Goncalves, Homero, Jr.
    Guerra, Maximiliano Ribeiro
    Duarte Cintra, Jane Rocha
    Fayer, Vivian Assis
    Brum, Igor Vilela
    Bustamante Teixeira, Maria Teresa
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
  • [38] Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
    Elisa Agostinetto
    Daniel Eiger
    Kevin Punie
    Evandro de Azambuja
    Current Oncology Reports, 2021, 23
  • [39] Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
    Jie Ping
    Shuya Huang
    Jie Wu
    Pingping Bao
    Timothy Su
    Kai Gu
    Hui Cai
    Xingyi Guo
    Loren Lipworth
    William J. Blot
    Wei Zheng
    Qiuyin Cai
    Xiao-Ou Shu
    Breast Cancer Research and Treatment, 2021, 186 : 769 - 777
  • [40] Expression of neuroendocrine markers predicts increased survival in triple-negative breast cancer patients
    Xia, Chuan
    Shen, Songjie
    Pang, Junyi
    Chen, Longyun
    Yan, Jie
    Liang, Zhiyong
    Ren, Xinyu
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14